Glimepiride exhibits prophylactic effect on atherosclerosis in cholesterol-fed rabbits

Atherosclerosis

Volumn 182, Issue 2, 2005, Pages 209-217

  Shakuto, Shuji ^a,b   Oshima, Kenichi ^a   Tsuchiya, Eiko ^b  

^a Aventis Pharma Ltd   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Cholesterol; Endothelial cell; Glimepiride; LDL oxidation; Sulfonylurea

Indexed keywords

GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY INTIMA; ARTICLE; ATHEROGENIC DIET; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; FOAM CELL; HEART PROTECTION; IC 50; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; THORACIC AORTA;

ANIMALS; AORTA; ATHEROSCLEROSIS; CELLS, CULTURED; CHOLESTEROL, DIETARY; COPPER; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; LIPID PEROXIDES; LIPOPROTEINS, LDL; MALE; RABBITS; SULFONYLUREA COMPOUNDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES;

EID: 24644446562     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.01.044     Document Type: Article

References (30)

1. J.A. Beckman, M.A. Creager, and P. Libby Diabetes and atherosclerosis: epidemiology, pathophysiology and management JAMA 287 2002 2570 2581
2. S. Lehto, T. Ronnemaa, and S.M. Haffner Dyslipidemia and hyperglycemia predict coronary heart disease events in middle aged patients with NIDDM Diabetes 46 1997 1354 1359
3. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
4. K. Geisen Special pharmacology of the new sulfonylurea glimepiride Arzneim-Forsch/Drug Res 38 1988 1120 1130
5. H. Langtry, and J. Balfour Glimepiride - a review of its use in the management of type 2 diabetes mellitus Drugs 55 1998 563 584
6. 2+]i elevation induced by arachidonic acid Biochem Pharmacol 49 1995 1735 1739
7. G. Marquie Preventive effect of gliclazide on experimental atherosclerosis in rabbits Diabetologia 14 1978 269 275
8. J. Paasikivi, and F. Walhlberg Preventive tolbutamide treatment and arterial disease in mild hyperglycaemia Diabetologia 7 1971 323 327
9. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum Beyond cholesterol: modifications of low-density lipoproteins that increase its atherogenicity N Engl J Med 320 1989 915 924
10. G.K. Hansson, P.S. Seifert, G. Olsson, and G. Bondjers Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits Arterioscler Thromb 11 1991 745 750
11. T. Kaneko, N. Sakamoto, and S. Nakagawa Optimal dose finding study of glimepiride (HOE 490) in non-insulin dependent diabetes mellitus J Clin Ther Med 9 1993 1107 1129
12. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can J Med Sci 37 1959 911 917
13. U.P. Steinbrecher, S. Parthasarathy, D.S. Leake, J.L. Witztum, and D. Steinberg Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids Proc Natl Acad Sci 81 1984 3883 3887
14. M.W. Stolar Atherosclerosis in diabetes: the role of hyperinsulinemia Metabolism 37 Suppl 1 1988 1 9
15. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
16. K. Yokote, N. Morisaki, and M. Zenibayashi The phospholipase-A2 reaction leads to increased monocyte adhesion of endothelial cells via the expression of adhesion molecules Eur J Biochem 217 1993 723 729
17. N. Kume, M.I. Cybulsky, and M.A. Gimbrone Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells J Clin Invest 90 1992 1138 1144
18. M.T. Quinn, S. Parthasarathy, and D. Steinberg Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis Proc Natl Acad Sci 85 1988 2805 2809
19. S. Yui, T. Sasaki, A. Miyazaki, S. Horiuchi, and M. Yamazaki Induction of murine macrophage growth by modified LDLs Arterioscler Thromb 13 1993 331 337
20. M. Yokoyama, K. Hirata, and R. Miyake Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein Biochem Biophys Res Commun 168 1990 301 308
21. L.W. Stanton, R.T. White, C.M. Bryant, A.A. Protter, and G. Endemann A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein J Biol Chem 267 1992 22446 22451
22. G. Endemann, L.W. Stanton, and K.S. Madden CD36 is a receptor for oxidized low density lipoprotein J Biol Chem 268 1993 11811 11816
23. 2 activity in endothelial cell-induced modification of low density lipoprotein Proc Natl Acad Sci 82 1985 3000 3004
24. 2 activity of apoprotein B-100 Proc Natl Acad Sci 87 1990 9741 9745
25. A.J. Marcus, B.B. Weksler, and E.A. Jaffe Enzymatic conversion of prostaglandin endoperoxide H2 and arachidonic acid to prostacyclin by cultured human endothelial cells J Biol Chem 253 1978 7138 7141
26. B.B. Weksler, C.W. Ley, and E.A. Jaffe Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187 J Clin Invest 62 1978 923 930
27. N.K. Hopkins, T.D. Oglesby, G.L. Bundy, and R.R. Gorman Biosynthesis and metabolism of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid by human umbilical vein endothelial cells J Biol Chem 259 1984 14048 14053
28. H. Takayama, M.A. Gimbrone Jr., and A.I. Schafer Vascular lipoxygenase activity: synthesis of 15-hydroxyeicosatetraenoic acid from arachidonic acid by blood vessels and cultured vascular endothelial cells Thromb Res 45 1987 803 816
29. S. Parthasarathy, E. Wieland, and D. Steinberg A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein Proc Natl Acad Sci 86 1989 1046 1050
30. V.W. van Hinsbergh, M. Scheffer, L. Havekes, and H.J. Kempen Role of endothelial cells and their products in the modification of low-density lipoproteins Biochim Biophys Acta 878 1986 49 64